One of the keys to successful investing is knowing the difference between long-term trends and short-term disruptions. That’s what Validea CEO John Reese says, and he says investors who can…
Category: Sector Data
Oberweis: With Biotech Pricey, Try Other Healthcare Options
Many biotech stocks have had exceptional runs over the past few years. But newsletter guru Jim Oberweis says that has led to some exorbitant valuations, and he says there are…
Tech Plays Offering More Value Than Google
Google grabbed headlines recently when the already-giant technology stock soared 16% in a single day. But in his latest for Forbes.com, Validea CEO John Reese says his Guru Strategies are…
Wien Bullish On Biotech, And The Economy
Top strategist Byron Wien thinks the economy will fare much better in the second half of the year, and says he is high on biotech stocks. (more…)
When It Comes To Tech Investing, Don't Overlook The Old Guard
In the tech sector, new companies with exciting stories often get the bulk of the attention — and the bulk of investors’ dollars. But in a recent interview with Canada’s…
When It Comes To Tech Investing, Don't Overlook The Old Guard
In the tech sector, new companies with exciting stories often get the bulk of the attention — and the bulk of investors’ dollars. But in a recent interview with Canada’s…
Top Fund Manager Keen On Japan
Dan Chamby, one of the co-managers of BlackRock’s top-performing Global Allocation Fund, is betting big on Japan. (more…)
The Case for Dow 85,000
It may seem hard to believe that the Dow Jones Industrial Average could increase nearly five-fold over the next 15 years. But two top strategists have recently laid out a…
Fisher On Technology's Bullish Laws
In his latest Forbes column, Kenneth Fisher looks at some technology “laws” that he says will continue to increase productivity and boost the economy. (more…)
Reese on The US's New Industrial Revolution
In his latest column for Seeking Alpha, Validea CEO John P. Reese takes a look at American industrial stocks. (more…)